Research Paper Volume 13, Issue 12 pp 16513—16526

Deoxyribonuclease 1-like 3 may be a potential prognostic biomarker associated with immune infiltration in colon cancer

Expression of deoxyribonuclease 1-like 3 (DNASE1L3) in colon cancer and its correlation with clinicopathology. (A) The expression of DNASE1L3 in colon cancer and normal samples (pB) Expression analysis of DNASE1L3 in colon cancer and paired normal samples (p=2.7e-12, Wilcoxon rank sum test). (C–F) The association between DNASE1L3 and clinicopathology (Kruskal–Wallis rank sum test or Wilcoxon rank sum test, statistical significance at p

Figure 4. Expression of deoxyribonuclease 1-like 3 (DNASE1L3) in colon cancer and its correlation with clinicopathology. (A) The expression of DNASE1L3 in colon cancer and normal samples (p<0.001, Wilcoxon rank sum test). (B) Expression analysis of DNASE1L3 in colon cancer and paired normal samples (p=2.7e-12, Wilcoxon rank sum test). (CF) The association between DNASE1L3 and clinicopathology (Kruskal–Wallis rank sum test or Wilcoxon rank sum test, statistical significance at p<0.05).